Compare · CONX vs EUCR
CONX vs EUCR
Side-by-side comparison of CONX Corp. (CONX) and Eucrates Biomedical Acquisition Corp. (EUCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CONX and EUCR operate in Blank Checks (Finance), so they compete in similar markets.
- CONX is the larger of the two at $919.0M, about 7.0x EUCR ($131.6M).
CONX Corp.
CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including the wireless communications industry. The company was incorporated in 2020 and is based in Littleton, Colorado.
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest CONX
- SEC Form 10-Q filed by CONX Corp.
- SEC Form SC 13D filed by CONX Corp.
- SEC Form SC 13D filed by CONX Corp.
- CONX Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- Ergen Charles W converted options into 18,750,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Gst-Exempt Ranch Legacy Trust
- CONX Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- CONX Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Regulation FD Disclosure, Financial Statements and Exhibits
- CONX Corp. Announces Closing of Initial Business Combination
- SEC Form SC 13G/A filed by CONX Corp. (Amendment)
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)